Yang Bo-Gie, Tanaka Toshiyuki, Jang Myoung Ho, Bai Zhongbin, Hayasaka Haruko, Miyasaka Masayuki
Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
J Immunol. 2007 Oct 1;179(7):4376-82. doi: 10.4049/jimmunol.179.7.4376.
Certain lymphoid chemokines are selectively and constitutively expressed in the high endothelial venules (HEV) of lymph nodes and Peyer's patches, where they play critical roles in the directional migration of extravasating lymphocytes into the lymphoid tissue parenchyma. How these chemokines are selectively localized and act in situ, however, remains unclear. In the present study, we examined the possibility that basal lamina-associated extracellular matrix proteins in the HEVs are responsible for retaining the lymphoid chemokines locally. Here we show that collagen IV (Col IV) bound certain lymphoid chemokines, including CCL21, CXCL13, and CXCL12, more potently than did fibronectin or laminin-1, but it bound CCL19 and CCL5 only weakly, if at all. Surface plasmon resonance analysis indicated that Col IV bound CCL21 with a low nanomolar K(D), which required the C-terminal region of CCL21. Col IV can apparently hold these chemokines in their active form upon binding, because the Col IV-bound chemokines induced lymphocyte migration efficiently in vitro. We found by immunohistochemistry that Col IV and CCL21, CXCL13, and CXCL12 were colocalized in the basal lamina of HEVs. When injected s.c. into plt/plt mice, CCL21 colocalized at least partially with Col IV on the basal lamina of HEVs in draining lymph nodes. Collectively, our results suggest that Col IV contributes to the creation of a lymphoid chemokine-rich environment in the basal lamina of HEVs by binding an array of locally produced lymphoid chemokines that promote directional lymphocyte trafficking from HEVs into the lymphoid tissue parenchyma.
某些淋巴细胞趋化因子在淋巴结和派尔集合淋巴结的高内皮小静脉(HEV)中选择性地组成性表达,它们在渗出的淋巴细胞向淋巴组织实质的定向迁移中起关键作用。然而,这些趋化因子如何在原位选择性定位并发挥作用仍不清楚。在本研究中,我们探讨了HEV中与基膜相关的细胞外基质蛋白在局部保留淋巴细胞趋化因子的可能性。在此我们表明,胶原蛋白IV(Col IV)比纤连蛋白或层粘连蛋白-1更有效地结合某些淋巴细胞趋化因子,包括CCL21、CXCL13和CXCL12,但它与CCL19和CCL5的结合很弱,甚至根本不结合。表面等离子体共振分析表明,Col IV以低纳摩尔的解离常数(K(D))结合CCL21,这需要CCL21的C末端区域。Col IV在结合后显然能使这些趋化因子保持其活性形式,因为与Col IV结合的趋化因子在体外能有效地诱导淋巴细胞迁移。我们通过免疫组织化学发现,Col IV与CCL21、CXCL13和CXCL12共定位于HEV的基膜中。当皮下注射到plt/plt小鼠体内时,CCL21至少部分地与引流淋巴结中HEV基膜上的Col IV共定位。总的来说,我们的结果表明,Col IV通过结合一系列促进淋巴细胞从HEV向淋巴组织实质定向运输的局部产生的淋巴细胞趋化因子,有助于在HEV的基膜中形成富含淋巴细胞趋化因子的环境。